PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Полное описание

Библиографические подробности
Главные авторы:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Формат:	Статья
Язык:	Russian
Опубликовано:	Remedium Group LLC 2017-11-01
Серии:	Медицинский совет
Предметы:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Online-ссылка:	https://www.med-sovet.pro/jour/article/view/2007

Схожие документы

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
по: Annina S. Vischer, и др.
Опубликовано: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
по: Chinonyerem O. Iheanacho, и др.
Опубликовано: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
по: Piotr Skonieczny, и др.
Опубликовано: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
по: Yang Zhao, и др.
Опубликовано: (2018-01-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
по: Chibuike C. Udenigwe, и др.
Опубликовано: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
по: Kuang-Ming Liao, и др.
Опубликовано: (2023-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
по: N.D. Filipets, и др.
Опубликовано: (2019-02-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
по: Jordan Loader, и др.
Опубликовано: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
по: Simon B. Gressens, и др.
Опубликовано: (2021-02-01)

Renin-angiotensin system blockers and COVID-19
по: Emmanuelle Vidal-Petiot, и др.
Опубликовано: (2021-06-01)

Angiotensins and rheumatoid arthritis
по: N. M. Savushkina, и др.
Опубликовано: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
по: JungMin Choi, и др.
Опубликовано: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
по: Leonard K. Wang, и др.
Опубликовано: (2023-06-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
по: Fabrizio Buffolo, и др.
Опубликовано: (2021-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
по: N. V. Drobotya, и др.
Опубликовано: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
по: Yipeng Fang, и др.
Опубликовано: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
по: Jilong XU, и др.
Опубликовано: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
по: Anna V. Aksenova, и др.
Опубликовано: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
по: S. V. Stolov
Опубликовано: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
по: Konstantinos Tziomalos, и др.
Опубликовано: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
по: T E Morozova
Опубликовано: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
по: K. A. Ghyamdzhyan, и др.
Опубликовано: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
по: Stine Andersen, и др.
Опубликовано: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
по: S Ravitej, и др.
Опубликовано: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
по: Hye-Jin Park, и др.
Опубликовано: (2022-01-01)

Perspectives of using angiotensin receptor antagonists
по: V V Fomin
Опубликовано: (2009-06-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
по: Steven M. Smith, и др.
Опубликовано: (2023-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
по: Ann Z. Bauer, и др.
Опубликовано: (2021-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
по: Joachim Beige
Опубликовано: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
по: José A. Carlos-Escalante, и др.
Опубликовано: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
по: Maksimov M.L., и др.
Опубликовано: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
по: M L Maksimov, и др.
Опубликовано: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
по: Hany A Al-Hussaniy, и др.
Опубликовано: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
по: Yohko Nagai, и др.
Опубликовано: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
по: M L Maksimov
Опубликовано: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
по: Kamryn E. Jones, и др.
Опубликовано: (2024-06-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
по: D.D. Ivanov, и др.
Опубликовано: (2021-09-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
по: Odifentse Mapula-e Lehasa, и др.
Опубликовано: (2024-08-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
по: Mishita Goel, и др.
Опубликовано: (2020-08-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
по: A. E. Bragina, и др.
Опубликовано: (2005-12-01)